Tag: Johnson & Johnson and Merck

Pharmaceutical Companies on Covid-19: Profit, Patent, & Population Health
Business

Pharmaceutical Companies on Covid-19: Profit, Patent, & Population Health

Why did pharmaceutical companies choose to research, produce, & distribute multiple Covid-19 vaccines instead of a singular non-patented drug? Why, now, are these pharmaceutical companies eventually partnering with their peers only for regional warehousing or local end-to-end supply chain? Why again Bill Gates disapproves of patent access to "poor countries" and Ron Klain acts smart? In the beginning, the biopharmaceutical and biotechnological companies took it as a challenge to produce their first Covid-19 vaccination instead of considering a singular, non-patented drug that helps build a global immunity shield against all strains of the novel coronavirus. Of course, that helped diversify the market, and consumers chose to pick their brand of the vaccine shot. But somewhere, did it al...
Skip to content